Actinic Keratoses Clinical Trials

LEO Pharma Protocol LP0084-1196: A phase 3, multi-centre, randomised, parallel group, double-blind, vehicle-controlled trial measuring the Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Balding Scalp including 12-month follow-up – ACTIVE

This is a phase 3 clinical trial investigating a topical ingenol-derivative in adult subjects with five to 20 actinic keratoses on the balding scalp.

The clinical research team at DermAssociates is committed to conducting clinical research in accordance with Good Clinical Practices and IHCP guidelines to ensure the trials are carried out safely and ethically. DermAssociates consistently seeks optimal results for its patients and has a proven record of meeting and exceeding expectations.